{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:08:11Z","timestamp":1788966491739,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Introduction<\/jats:bold>\n                    Type 2 diabetes (T2D) is a global health challenge conferring significant morbidity and mortality with accelerated cardiovascular, renovascular and cerebrovascular disease. Periodontitis has a higher prevalence in people with diabetes. We aimed to evaluate the risk of incident cardiovascular-related diseases in people with type 2 diabetes with and without periodontitis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    We conducted a retrospective cohort study using TriNetX, a global federated health research network of patients \u226518 years with a diagnosis of T2D after the initiation of insulin. Cohorts were divided based on the absence or presence of periodontitis identified using ICD-10 (International Classification of Diseases) codes. Outcomes were recorded at three years from initiation of insulin. The primary outcomes of interest were: 1) mortality; 2) myocardial infarction; 3) stroke; 4) dementia; 5) atrial fibrillation; 6) atrial flutter; 7) diabetic nephropathy; 8) diabetic retinopathy; and 9) infective endocarditis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    After propensity score matching (1:1), a total of 56,525 patients were identified in each cohort. At three years, patients with periodontitis had similar mortality risk as the control group (risk ratio [RR] plus 95% confidence interval [CI]) (RR: 1.014, 0.979\u20131.049;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.44). However, the periodontitis cohort demonstrated higher risk of stroke (RR: 1.264, 1.189\u20131.344;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), myocardial infarction (RR: 1.151, 1.084\u20131.222;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), atrial fibrillation (RR: 1.141, 1.08\u20131.205;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), atrial flutter (RR: 1.21, 1.1\u20131.331;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), diabetic retinopathy (RR: 1.735, 1.648\u20131.826;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), diabetic nephropathy (RR: 1.433, 1.35\u20131.521;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001), infective endocarditis (RR: 1.83, 1.627\u20132.059;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001) and dementia (RR: 1.364, 1.254\u20131.483;\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.0001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    Our findings add to the growing body of evidence that periodontitis is associated with long-term cardiovascular consequences in people with T2D. However, due to the study's retrospective nature, there is a need for well-designed, prospective research, including mechanistic and interventional studies to further explore this relationship.\n                  <\/jats:p>","DOI":"10.1038\/s41415-025-8889-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:18Z","timestamp":1761057258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased cardiovascular risk in people with type 2 diabetes and periodontitis: an analysis from a global real-world federated database"],"prefix":"10.1038","author":[{"given":"Hani","family":"Essa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iram","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Henney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos","family":"Albadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"8889_CR6177","doi-asserted-by":"crossref","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023; 402: 203\u2013234.","DOI":"10.1016\/S0140-6736(23)01301-6"},{"key":"8889_CR6179","doi-asserted-by":"crossref","unstructured":"Ahmad E, Lim S, Lamptey R, Webb D R, Davies M J. Type 2 diabetes. Lancet 2022; 400: 1803\u20131820.","DOI":"10.1016\/S0140-6736(22)01655-5"},{"key":"8889_CR6181","doi-asserted-by":"crossref","unstructured":"Saeedi P, Salpea P, Karuranga S et al. Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2020; 162: 108086.","DOI":"10.1016\/j.diabres.2020.108086"},{"key":"8889_CR6184","doi-asserted-by":"crossref","unstructured":"Preshaw P M, Alba A L, Herrera D et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012; 55: 21\u201331.","DOI":"10.1007\/s00125-011-2342-y"},{"key":"8889_CR6186","doi-asserted-by":"crossref","unstructured":"Darveau R P. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010; 8: 481\u2013490.","DOI":"10.1038\/nrmicro2337"},{"key":"8889_CR6188","doi-asserted-by":"crossref","unstructured":"Hasan A, Palmer R M. A clinical guide to periodontology: pathology of periodontal disease. Br Dent J 2014; 216: 457\u2013461.","DOI":"10.1038\/sj.bdj.2014.299"},{"key":"8889_CR6191","doi-asserted-by":"crossref","unstructured":"Preshaw P M, Bissett S M. Periodontitis and diabetes. Br Dent J 2019; 227: 577\u2013584.","DOI":"10.1038\/s41415-019-0794-5"},{"key":"8889_CR6193","doi-asserted-by":"crossref","unstructured":"Nguyen A T M, Akhter R, Garde S et al. The association of periodontal disease with the complications of diabetes mellitus. A systematic review. Diabetes Res Clin Pract 2020; 165: 108244.","DOI":"10.1016\/j.diabres.2020.108244"},{"key":"8889_CR6195","doi-asserted-by":"crossref","unstructured":"Graziani F, Gennai S, Solini A, Petrini M. A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes. An update of the EFP-AAP review. J Clin Periodontol 2018; 45: 167\u2013187.","DOI":"10.1111\/jcpe.12837"},{"key":"8889_CR6197","doi-asserted-by":"crossref","unstructured":"Fowler E B, Breault L G, Cuenin M F. Periodontal disease and its association with systemic disease. Mil Med 2001; 166: 85\u201389.","DOI":"10.1093\/milmed\/166.1.85"},{"key":"8889_CR6200","doi-asserted-by":"crossref","unstructured":"Trullenque-Eriksson A, Tomasi C, Eeg-Olofsson K, Berglundh T, Petzold M, Derks J. Periodontitis in patients with diabetes and its association with diabetes-related complications. A register-based cohort study. BMJ Open 2024; DOI: 10.1136\/bmjopen-2024-087557.","DOI":"10.1136\/bmjopen-2024-087557"},{"key":"8889_CR6202","doi-asserted-by":"crossref","unstructured":"Palchuk M B, London J W, Perez-Rey D et al. A global federated real-world data and analytics platform for research. JAMIA Open 2023; DOI: 10.1093\/jamiaopen\/ooad035.","DOI":"10.1093\/jamiaopen\/ooad035"},{"key":"8889_CR6204","doi-asserted-by":"crossref","unstructured":"VanderWeele T J, Ding P. Sensitivity analysis in observational research: introducing the e-value. Ann Intern Med 2017; 167: 268\u2013274.","DOI":"10.7326\/M16-2607"},{"key":"8889_CR6206","doi-asserted-by":"crossref","unstructured":"St\u00f6hr J, Barbaresko J, Neuenschwander M, Schlesinger S et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep 2021; 11: 13686.","DOI":"10.1038\/s41598-021-93062-6"},{"key":"8889_CR6209","doi-asserted-by":"crossref","unstructured":"Saini R, Saini S, Sugandha R. Periodontal disease: the sixth complication of diabetes. J Fam Community Med 2011; 18: 31.","DOI":"10.4103\/1319-1683.78636"},{"key":"8889_CR6211","doi-asserted-by":"crossref","unstructured":"Stoicescu M, Calniceanu H, Tig I et al. Significant aspects and correlation between glycemic control and generalized chronic periodontitis in type 2 diabetes mellitus patients. Exp Ther Med 2021; 22: 671.","DOI":"10.3892\/etm.2021.10103"},{"key":"8889_CR6213","doi-asserted-by":"crossref","unstructured":"Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 2013; DOI: 10.1902\/jop.2013.134008.","DOI":"10.1902\/jop.2013.134008"},{"key":"8889_CR6216","doi-asserted-by":"crossref","unstructured":"Sen S, Giamberardino L D, Moss K et al. Periodontal disease, regular dental care use, and incident ischemic stroke. Stroke 2018; 49: 355\u2013362.","DOI":"10.1161\/STROKEAHA.117.018990"},{"key":"8889_CR6219","doi-asserted-by":"crossref","unstructured":"Park S-Y, Kim S-H, Kang S-H et al. Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea. Eur Heart J 2019; 40: 1138\u20131145.","DOI":"10.1093\/eurheartj\/ehy836"},{"key":"8889_CR6221","doi-asserted-by":"crossref","unstructured":"Ahn Y-B, Shin M-S, Han D-H et al. Periodontitis is associated with the risk of subclinical atherosclerosis and peripheral arterial disease in Korean adults. Atherosclerosis 2016; 251: 311\u2013318.","DOI":"10.1016\/j.atherosclerosis.2016.07.898"},{"key":"8889_CR6225","doi-asserted-by":"crossref","unstructured":"Lu B, Parker D, Eaton C B. Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999\u20132002 data. Atherosclerosis 2008; 200: 199\u2013205.","DOI":"10.1016\/j.atherosclerosis.2007.12.037"},{"key":"8889_CR6227","doi-asserted-by":"crossref","unstructured":"Mondal R, Ritu R B, Kitaoka K et al. Oral microbiome alpha diversity and all-cause, cardiovascular, and non-cardiovascular mortality in US adults: evidence from the NHANES 2009\u20132019. Atherosclerosis 2024; 401: 119074.","DOI":"10.1016\/j.atherosclerosis.2024.119074"},{"key":"8889_CR6229","doi-asserted-by":"crossref","unstructured":"Chang Y, Woo H G, Park J, Lee J S, Song T-J. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: a nationwide population-based cohort study. Eur J Prev Cardiol 2020; 27: 1835\u20131845.","DOI":"10.1177\/2047487319886018"},{"key":"8889_CR6232","doi-asserted-by":"crossref","unstructured":"Guo H, Chang S, Pi X et al. The effect of periodontitis on dementia and cognitive impairment: a meta-analysis. Int J Environ Res Public Health 2021; 18: 6823.","DOI":"10.3390\/ijerph18136823"},{"key":"8889_CR6234","doi-asserted-by":"crossref","unstructured":"Tonetti M S, Greenwell H, Kornman K S. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 2018; DOI: 10.1002\/JPER.18-0006.","DOI":"10.1002\/JPER.18-0006"},{"key":"8889_CR6236","doi-asserted-by":"crossref","unstructured":"Tang D, Chen M, Huang X et al. SRplot: a free online platform for data visualization and graphing. PLos One 2023; DOI: 10.1371\/journal.pone.0294236.","DOI":"10.1371\/journal.pone.0294236"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-025-8889-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-025-8889-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-025-8889-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:52:24Z","timestamp":1762260744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-025-8889-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":26,"alternative-id":["8889"],"URL":"https:\/\/doi.org\/10.1038\/s41415-025-8889-7","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HE, IW, SSZ, SA, AH, GH and IY report no conflicts of interest. UA has received honoraria from Viatris, Gr\u00fcnenthal, Eli Lilly, Procter & Gamble for educational meetings and has received investigator-led funding from Procter & Gamble. UA has received sponsorship to attend educational meetings from Daiichi Sankyo and Sanofi. GYHL is a National Institute for Health and Care Research (NIHR) Senior Investigator. He is Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos (no fees are received personally). He is co-PI\/lead of the AFFIRMO project on multimorbidity in AF (grant agreement no. 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (grant agreement no. 101136244) and ARISTOTELES project on artificial intelligence for management of chronic long term conditions (grant agreement no. 101080189), which are all funded by the EU's Horizon Europe Research & Innovation programme. GH is a full-time employee of TriNetX LLC. The TriNetX platform is a federated network that provides access only to de-identified data, and analyses performed on the platform do not require ethical approval or informed consent. This is accordance with all data protection laws applicable to the underlying healthcare organisations (HCOs), including the EU General Data Protection Regulation (Regulation 2016\/679, GDPR) and the US Health Insurance Portability and Accountability Act. Written informed consent to participate in this study is not required in accordance with the relevant legislation. Network analytics are performed locally at each participating HCO, with only aggregate counts and statistical summary results being returned to the TriNetX platform. The platform does not provide access to any personal data or protected health information, ensuring that individual patients cannot be identified. All participating HCOs affirm that they have the necessary rights, consents, approvals, and authority to share de-identified data with TriNetX under a business associate agreement for research purposes. Because our research involves only secondary analysis of de-identified, aggregate data with no direct patient interaction or identifiable private information, it is considered exempt from institutional review board or ethics committee review under applicable regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}]}}